Heart failure secondary to myocarditis after SARS-CoV-2 reinfection: a case report

Cardiac involvement in COVID-19 can range from mild damage to severe myocarditis. SARS-CoV-2 binds with high affinity to the human angiotensin-converting enzyme receptor 2 (ACE 2), which is expressed in the entire body, including the heart. Severe systemic manifestations, such as myocarditis, have been reported in association with the coronavirus disease 2019 (COVID-19) (Kerneis et al., 2020; Hamming et al., 2004). Some COVID-19 patients have persistent tachycardia, sustained asymptomatic hypotension, and bradycardia (Huang et al., 2020).

Source: International Journal of Infectious Diseases - October 20, 2021 Category: Infectious Diseases Authors: Patr ícia Gabriela Riedel, Vitoria Fedrizzi Sakai, Sheila de Castro Cardoso Toniasso, Maria Carlota Borba Brum, Fernando Schmidt Fernandes, Robson Martins Pereira, Camila Pereira Baldin, Cícero de Campos Baldin, Anderson Yudi Takahasi, Hugo Sakai, Ana M Tags: Case Report Source Type: research